Introduction to IT and Telecommunications (IT & Tel)* o Introduction to Infrastructure (Infra. Mgt.)* o Industrial Pharmacy and Pharmaceutical Technology (Pharma. Mgt.)* o Hospital Planning and Organization (Hosp. Mgt.)* MBA-122 *R. Mgt= Retail Management; B&I= Banking & Insurance; IT & Tel.= IT & Telecommunication; Infra. Mgt.=Infrastructural Management; Pharma. Mgt.=Pharmaceutical Management; Hosp. Mgt.=Hospital Management. TRIMESTER – III CODE MBA-133 MBA-143 MBA-153 MBA-163a MBA-163b PAPER Legal
Words: 30662 - Pages: 123
ALOK KEJARIWAL 1PI11MBA13 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants
Words: 4668 - Pages: 19
Pharmaceuticals and Life Sciences Global pharma looks to India: Prospects for growth Table of contents Introduction 03 Background 04 A fast growing economy An expanding pharmaceutical market Government-provided healthcare improving, but private healthcare dominates Domestic market overview 09 Background Consolidation underway, despite challenges Contract manufacturing Vaccines Over the counter market holds significant potential Reaching the untapped rural market
Words: 17333 - Pages: 70
structure? What five forces determine industry structure? What is competitive strategy? What is a value chain? How do value chains determine business processes and information systems? How do information systems provide competitive advantages? How does the knowledge in this chapter help Dee and you? 37 38 Chapter 3 Organizational Strategy, Information Systems, and Competitive Advantage Industry Structure New Vendors Competitive Strategy Value Chains Business Processes Information
Words: 8410 - Pages: 34
Pharmaceutical Cluster in Andhra Pradesh Microeconomics of Competitiveness Final Project Harvard Business School Helene Herve | Lhakpa Bhuti | Saurabh Agarwal | Sonny Kushwaha | Akbar Causer May 2013 Table of Contents 1 2 Executive Summary ............................................................................................................................ 3 Introduction to India .........................................................................................................
Words: 9670 - Pages: 39
you take? Pharmaceuticals and Life Sciences Previous publications in this series include: Pharmaceuticals Pharma 2020: The vision Which path will you take?* Published in June 2007, this paper highlights a number of issues that will have a major bearing on the industry by 2020. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike. Pharmaceuticals and Life
Words: 13197 - Pages: 53
PHILOSOPHY 4 2.0 SITUTATION ANALYSIS 5 2.1 GENERAL COMPANY DESCRIPTION 5 2.2 MARKET SUMMARY 6 2.2.1 MARKET TRENDS 6 2.2.2 MARKET GROWTH 6 2.2.3 MARKET DEMOGRAPHICS 6 2.2.4 TECHNOLOGICAL FORCES 6 2.2.5 POLITICAL LEGAL REGULATIONS 7 2.3 SWOT ANALYIS 8 2.3.1 STRENGTHS 8 2.3.2 WEAKNESSES 8 2.3.3 OPPORTUNITIES 8 2.3.4 THREATS 9 2.4 PRODUCT OFFERING 9 3.0 COMPETITIVE ANALYSIS 10 3.1 COMPETITORS 11 3.2 COMPETITOR ANALYSIS 12 4.0 SPECIFIC BUSINESS GROWTH
Words: 3078 - Pages: 13
1/1/2012 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants
Words: 4681 - Pages: 19
management addresses the organizational structure, resources & capabilities, and the strategic positioning of the organization to create, capture, and sustain competitive advantage. In addition to economic value creation, management also must make decisions concerning the distribution of this economic value across stakeholders. In BADM 449, you will develop your skills at: • Understanding how firms create, capture, and sustain competitive advantage; • Analyzing strategic business situations and formulating
Words: 5629 - Pages: 23
sourcing of raw materials and the complex, energyintensive chemical processes involved in transforming them into our products accounts for around half of our value chain carbon footprint. Over the last five years, we have been using innovative technology to reduce environmental impacts associated with manufacturing active pharmaceutical ingredients – the substances in our drugs that treat or prevent illness. Following trials in Jurong, Singapore, teams at the eight facilities where we
Words: 4935 - Pages: 20
